Examkin

Soru

Zorluk: Çok zorHypothesis Testing and Statistical Power

An integrated health system initiates a pragmatic randomized controlled trial to assess a novel electronic health record (EHR) alert designed to prevent acute kidney injury (AKI) in patients receiving nephrotoxic medications. The investigators calculate a required sample size of 4,500 patient encounters to achieve 90% statistical power (β=0.10\beta = 0.10) to detect a 25% relative reduction in AKI incidence, utilizing a two-tailed α\alpha of 0.05. This calculation is based on historical data showing a baseline AKI incidence of 12% in this population.

Six months into the trial, a blinded interim analysis reveals that the overall pooled incidence of AKI across both the intervention and control arms is only 6%. Investigation reveals this is likely due to a hospital-wide intravenous hydration protocol implemented independently just before the trial began. The investigators determine that a 25% relative reduction in AKI remains the minimum clinically important difference they wish to detect.

If the investigators proceed without altering the planned sample size of 4,500 encounters, which of the following describes the most accurate statistical consequence of this unexpected drop in baseline incidence?

  1. The statistical power to detect the 25% relative reduction will decrease, increasing the probability of a Type II error.Cevap
  2. B
    The hydration protocol will introduce confounding, requiring a stratified analysis to accurately estimate the treatment effect.
  3. C
    The predictive value of a statistically significant finding will increase due to the lower overall prevalence of the outcome.
  4. D
    The reduced event rate will necessitate the use of a non-parametric statistical test to compare the two groups.
  5. E
    The minimum detectable relative effect size will decrease, allowing the trial to be sensitive to smaller clinical differences.

Cevap

The statistical power to detect the 25% relative reduction will decrease, increasing the probability of a Type II error.
The correct answer identifies that a decrease in the baseline incidence rate significantly reduces the total number of expected outcome events in the trial. Statistical power is highly dependent on the number of events. When the baseline rate drops from 12% to 6%, a 25% relative risk reduction corresponds to an absolute risk reduction of only 1.5% (down from the originally planned 3.0%). Detecting a smaller absolute difference with fewer total events requires a much larger sample size. Because the investigators are keeping the sample size fixed at 4,500 encounters, the study becomes severely underpowered for the new 1.5% absolute difference. This loss of statistical power directly increases the risk of a Type II error (failing to detect a true difference).

Adım Adım Çözüm

1
Identify the primary change in the study's parameters.
The baseline incidence of the outcome (AKI) unexpectedly dropped from 12% to 6%.
Recognizing the altered variable is necessary to determine its downstream effects on the trial's statistical calculations.
2
Calculate the impact of this change on the expected absolute risk reduction.
Originally: 25% relative reduction of a 12% baseline = 3% absolute reduction. Now: 25% relative reduction of a 6% baseline = 1.5% absolute reduction.
Statistical power depends on the absolute difference between groups, not just the relative difference.
3
Relate the absolute risk reduction and overall event count to statistical power.
A smaller absolute difference (1.5%) and a lower total number of expected events require a significantly larger sample size to detect with 90% power.
In event-driven trials, power is primarily driven by the total number of observed outcomes.
4
Determine the consequence of keeping the sample size fixed at the original number.
Since the sample size remains 4,500, the study lacks the required data points to detect the 1.5% absolute difference. Power decreases, meaning β\beta (Type II error rate) increases.
Power and Type II error are inversely related (Power = 1−β1 - \beta).

Anahtar Kavram

In clinical trials with binary outcomes, statistical power depends heavily on the baseline event rate. If the baseline event rate is lower than expected, the absolute number of events decreases, which significantly reduces the study's power and increases the risk of a Type II error unless the sample size is proportionally increased.
Tahmini Süre:3m 0s
Bu soruyu puanla

Konular

Hypothesis Testing and Statistical Power

Bu konudan daha fazla soru